Loading clinical trials...
Loading clinical trials...
A Randomized, Crossover Study to Assess the Relative Bioavailability of Eicosapentaenoic Acid and Docosahexaenoic Acid in a Self-micro-emulsifying Delivery System (SMEDS) Formulation Compared With a Standard Omega-3-acid Ethyl Ester Product
Conditions
Interventions
EPA + DHA in SMEDS Formulation
Lovaza (active comparator; already FDA approved)
Locations
2
United States
MB Clinical Research, LLC
Boca Raton, Florida, United States
Great Lakes Clinical Trials
Chicago, Illinois, United States
Start Date
February 16, 2018
Primary Completion Date
April 5, 2018
Completion Date
April 15, 2018
Last Updated
March 23, 2023
NCT07063173
NCT07345130
NCT07046975
NCT06882681
NCT06641245
NCT06177483
Lead Sponsor
Midwest Center for Metabolic and Cardiovascular Research
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions